Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin.
van den Berg
J S
JS
van Engelen
B G
BG
Boerman
R H
RH
de Baets
M H
MH
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D020386:Isaacs Syndrome / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000188:drug therapy* / Q000209:etiology; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone